Skip to main content
Article thumbnail
Location of Repository

Enhanced nigrostriatal neuron-specific, long-term expression by using neural-specific promoters in combination with targeted gene transfer by modified helper virus-free HSV-1 vector particles

By Haiyan Cao, Guo-rong Zhang, Xiaodan Wang, Lingxin Kong and Alfred I Geller
Topics: Methodology Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (1997). AI: An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell typespecific expression in the midbrain.
    2. (2005). AI: Comparison of protection of nigrostriatal neurons by expression of GDNF, BDNF, or both neurotrophic factors. Brain Res
    3. (2003). AI: Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector. Hum Gene Ther
    4. (1999). AI: Diverse stabilities of expression in the rat brain from different cellular promoters in a helper virusfree herpes simplex virus type 1 vector system. Hum Gene Ther
    5. (2001). AI: Enhanced auditory reversal learning by genetic activation of protein kinase C in small groups of rat hippocampal neurons. Molec Brain Res
    6. (2001). AI: Enhanced reporter gene expression in the rat brain from helper virusfree HSV-1 vectors packaged in the presence of specific mutated HSV-1 proteins that affect the virion. Molec Brain Res
    7. (1996). AI: Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. Biotechniques
    8. (1996). AI: Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells.
    9. (1996). AI: Longterm persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression. Gene Ther
    10. (2005). AI: Targeted gene transfer to nigrostriatal neurons in the rat brain by helper virusfree HSV-1 vector particles that contain either a chimeric HSV-1 glycoprotein C – GDNF or a gC – BDNF protein. Molec Brain Res
    11. (1993). AJ: A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology
    12. (1988). Breakefield XO: A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science
    13. (2004). Breakefield XO: HSV-1 virions engineered for specific binding to cell surface receptors. Mol Ther
    14. (1993). Collins F: GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science
    15. (2003). Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med
    16. (1995). Eisenberg RJ: Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules.
    17. (1996). et al.: Characterization of a multicomponent receptor for GDNF. Nature
    18. (1998). et al.: Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons.
    19. (1992). Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology
    20. (1993). Felsenfeld G: A 5' element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell
    21. (2005). Glorioso JC: Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging molecule. Mol Ther
    22. (2005). Herpes simplex virus 1 recombinant virions exhibiting the amino terminal fragment of urokinase-type plasminogen activator can enter cells via the cognate receptor. Gene Ther
    23. (1997). Herpes simplex virus-1 plasmid vectors for gene transfer into neurons. Adv Neurol
    24. (2003). Herpesvirus entry: an update.
    25. (1996). I: Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat Biotechnol
    26. (1998). JC: Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-tocell spread.
    27. (1987). KL: Organization and evolution of the rat tyrosine hydroxylase gene. Biochemistry
    28. (2003). Ligand-directed targeting of genes to the site of disease. Nat Med
    29. (2001). M: GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area.
    30. (2004). Multicenter, doubleblind, randomized, placebo-controlled, parallel group trial of liatermin (rmetHuGDNF) administered by bilateral intraputaminal (IPu) infusion to subjects with idiopathic Parkinson's disease. American Neurological Association:
    31. (1995). Neurons differentially control expression of a herpes simplex virus type 1 immediate-early promoter in transgenic mice.
    32. (1994). Olofsson S: Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate.
    33. (1994). PG: Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B.
    34. (2003). Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology
    35. (1998). Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.
    36. (1991). RL: Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors. Trends Neurosci
    37. (1991). RM: BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature
    38. (2005). Roizman B: Characterization of a Recombinant Herpes Simplex Virus 1 Designed To Enter Cells via the IL13R{alpha}2 Receptor of Malignant Glioma Cells. J Virol
    39. (1997). SC: Immunocytochemical localization of TrkB in the central nervous system of the adult rat.
    40. (1994). Schlaepfer WW: Brain-specific enhancement of the mouse neurofilament heavy gene promoter in vitro.
    41. Sears AE: Herpes simplex viruses and their replication. In The human herpesviruses Edited by: Roizman B, Whitley RJ,
    42. (1999). Seroogy KB: Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study.
    43. (2001). Spear PG: Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry.
    44. (2001). T: Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C.
    45. (1999). Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem
    46. (1996). TH: Prolonged in vivo gene expression driven by a tyrosine hydroxylase promoter in a defective herpes simplex virus amplicon vector. Hum Gene Ther
    47. (1986). The rat brain in stereotaxic coordinates Sidney:
    48. (2003). Trepel M: Random peptide libraries displayed on adenoassociated virus to select for targeted gene therapy vectors. Nat Biotechnol
    49. (2002). WJ: Neurons differentially activate the herpes simplex virus type 1 immediate-early gene ICP0 and ICP27 promoters in transgenic mice.
    50. (2001). WJ: The transgenic ICP4 promoter is activated in Schwann cells in trigeminal ganglia of mice latently infected with herpes simplex virus type 1. J Virol
    51. (1994). YW: Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.